Cardiac regeneration

January 6, 2021

Sleeve gastrectomy as a regenerative cardiovascular therapy: Sleeve gastrectomy inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 6/January/2021, 11.33 pm

Sleeve gastrectomy as a regenerative cardiovascular therapy: Sleeve gastrectomy inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 6/January/2021, 11.33 pm https://genomediscovery.org/wp-content/uploads/2021/01/Sleeve-gastrectomy-improves-myocardium-function-after-myocardial-infarctio-through-up-regulation-of-PNUTS-1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2021/01/Sleeve-gastrectomy-improves-myocardium-function-after-myocardial-infarctio-through-up-regulation-of-PNUTS-1.jpg January 6, 2021 January 6, 2021

What they say: A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March 2013 issue of the journal Nature, by Profs. Stefanie Dimmeler…

January 1, 2021

Regenerative cardiovascular therapy: ELK1 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 1/January/2021, 11.49 pm

Regenerative cardiovascular therapy: ELK1 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 1/January/2021, 11.49 pm https://genomediscovery.org/wp-content/uploads/2021/01/ELK1-based-therapy-improves-functional-recovery-after-Myocardial-infarction.jpg3_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2021/01/ELK1-based-therapy-improves-functional-recovery-after-Myocardial-infarction.jpg3_.jpg January 1, 2021 January 1, 2021

December 18, 2020

LncRNA-based regenerative cardiovascular therapy: LncRNA SNHG14 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 18/December/2020, 9.55 pm

LncRNA-based regenerative cardiovascular therapy: LncRNA SNHG14 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 18/December/2020, 9.55 pm https://genomediscovery.org/wp-content/uploads/2020/12/LncRNA-SNHG14-based-therapy-improves-functional-recovery-after-Myocardial-infarction1.png 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2020/12/LncRNA-SNHG14-based-therapy-improves-functional-recovery-after-Myocardial-infarction1.png December 18, 2020 December 18, 2020

December 18, 2020

CircRNA-based regenerative cardiovascular therapy: Circ-ASH2L inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration and survival after myocardial infarction, via up-regulation of its target gene, 18/December/2020, 9.20 pm

CircRNA-based regenerative cardiovascular therapy: Circ-ASH2L inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration and survival after myocardial infarction, via up-regulation of its target gene, 18/December/2020, 9.20 pm https://genomediscovery.org/wp-content/uploads/2020/12/Circ-ASH2-based-therapy-improves-functional-recovery-after-Myocardial-infarction2.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2020/12/Circ-ASH2-based-therapy-improves-functional-recovery-after-Myocardial-infarction2.jpg December 18, 2020 December 18, 2020

December 13, 2020

LNCRNA-based regenerative cardiovascular therapy: LncRNA Oip5-as1 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration and survival after myocardial infarction, via up-regulation of its target gene, 13/December/2020, 1.54 pm

LNCRNA-based regenerative cardiovascular therapy: LncRNA Oip5-as1 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration and survival after myocardial infarction, via up-regulation of its target gene, 13/December/2020, 1.54 pm https://genomediscovery.org/wp-content/uploads/2020/12/LncRNA-Oip5-as1-based-therapy-improves-functional-recovery-after-Myocardial-infarction3.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2020/12/LncRNA-Oip5-as1-based-therapy-improves-functional-recovery-after-Myocardial-infarction3.jpg December 13, 2020 December 18, 2020

December 13, 2020

LNCRNA-based regenerative cardiovascular therapy: Sirt1 antisense lncRNA inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration and survival after myocardial infarction, via up-regulation of its target gene, 13/December/2020, 1.42 pm

LNCRNA-based regenerative cardiovascular therapy: Sirt1 antisense lncRNA inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration and survival after myocardial infarction, via up-regulation of its target gene, 13/December/2020, 1.42 pm https://genomediscovery.org/wp-content/uploads/2020/12/Lnc-RNA-Sirt1-AS-Antisense-lncRNA-prevents-cardiomyocyte-dysfunction-and-cardiac-ageing-through-up-regulation-of-PNUTS-3.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2020/12/Lnc-RNA-Sirt1-AS-Antisense-lncRNA-prevents-cardiomyocyte-dysfunction-and-cardiac-ageing-through-up-regulation-of-PNUTS-3.jpg December 13, 2020 December 13, 2020

Regenerative cardiovascular therapy: ELK1 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 1/January/2021, 11.49 pm

Popular Post